{
    "title": "113_hr5790",
    "content": "The Act titled \"Health Prizes Rewarding Innovation, Savings, and Effectiveness Act of 2014\" introduces prize competitions for improving health outcomes and reducing federal expenditures under the Public Health Service Act. The Health Prizes Rewarding Innovation, Savings, and Effectiveness Act of 2014 aims to improve health outcomes and reduce Federal expenditures on health programs through prize competitions. The Director of NIH, in consultation with relevant parties, will identify 3 to 5 diseases or health conditions with significant Federal spending on prevention and treatment activities. The Health Prizes Rewarding Innovation, Savings, and Effectiveness Act of 2014 highlights the need for increased research investment in comparison to other diseases. The Director of NIH will design prize competitions to encourage innovation in addressing identified diseases or conditions. The Health Prizes Rewarding Innovation, Savings, and Effectiveness Act of 2014 directs the Director of NIH to design prize competitions for innovative solutions to identified diseases or conditions. Competitors will be awarded prizes based on the most promising or best solutions, ensuring a realistic design without bias towards specific types of innovations. The Health Prizes Rewarding Innovation, Savings, and Effectiveness Act of 2014 mandates the Director of NIH to create unbiased prize competitions for innovative solutions to diseases. Competitors can participate regardless of their location or background. The Director must consult with various experts and federal agency heads in designing these competitions. The Director of NIH is required to consult with medical, economic, budgetary, innovation, and venture capital experts, as well as heads of relevant Federal agencies, to design unbiased prize competitions for innovative solutions to diseases. The Director shall conduct a simulation of the prize competitions within 14 months of the enactment of the Act, and submit a report on the results to Congress within 4 months of awarding contracts for the simulation. The Director of NIH will adjust the design of prize competitions based on simulation results and submit a report to Congress. Private entities will implement the competitions as per the adjusted designs. The Director of NIH will conduct up to 5 prize competitions, with a maximum of 2 competitions per disease or condition. Competitors must demonstrate the effectiveness of their innovations within 5 years. The Secretary and Commissioner may provide guidance and testing facilities to qualified competitors. The Director of NIH will collect information on the medical efficacy and impact on Federal expenditures of innovations funded through prize competitions. A report will be submitted to Congress annually for five years after the conclusion of the competitions. The Federal Government is prohibited from acquiring intellectual property rights without the participant's written consent. The Federal Government cannot acquire intellectual property developed in prize competitions without the participant's consent. Appropriations of $50,000,000 are authorized for this purpose, with a minimum of 70% of assistance going towards implementing the competitions. The Federal Government authorizes $50,000,000 for prize competitions, with at least 70% of the assistance awarded as prizes to competitors. Prizes received under these competitions are excluded from gross income for improving health outcomes."
}